Literature DB >> 15664262

Cyclosporine protects against ischemia/reperfusion injury in rat kidneys.

Devinder Singh1, Vikas Chander, Kanwaljit Chopra.   

Abstract

Renal ischemia followed by reperfusion leads to acute renal failure in both native kidneys and renal allografts. Cyclosporine A (CsA) has been used as an immunosuppressive agent in organ transplantation. In the present study, the effect of CsA on ischemia/reperfusion (I/R)-induced injury in the kidney was investigated. Ischemia/reperfusion injury caused a significant deterioration in the renal function, morphology and gave rise to a severe oxidative stress in the kidney. At 3 mg/kg i.v., CsA significantly improved the functional and histological parameters and attenuated the oxidative stress induced by renal ischemia/reperfusion. From the results of our study, it can be concluded that low-dose CsA pretreatment preconditions the rat kidneys against subsequent ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664262     DOI: 10.1016/j.tox.2004.09.018

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  25 in total

1.  Drp1 dephosphorylation in ATP depletion-induced mitochondrial injury and tubular cell apoptosis.

Authors:  Sung-Gyu Cho; Quansheng Du; Shuang Huang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-21

2.  Cyclophilin D and the mitochondrial permeability transition in kidney proximal tubules after hypoxic and ischemic injury.

Authors:  Jeong Soon Park; Ratna Pasupulati; Thorsten Feldkamp; Nancy F Roeser; Joel M Weinberg
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-13

3.  Urinary mitochondrial DNA copy number identifies renal mitochondrial injury in renovascular hypertensive patients undergoing renal revascularization: A Pilot Study.

Authors:  A Eirin; S M Herrmann; A Saad; A Abumoawad; H Tang; A Lerman; S C Textor; L O Lerman
Journal:  Acta Physiol (Oxf)       Date:  2019-03-13       Impact factor: 6.311

Review 4.  Mitochondria: a pathogenic paradigm in hypertensive renal disease.

Authors:  Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2014-11-17       Impact factor: 10.190

Review 5.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

Review 6.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 7.  Mitochondrial injury and dysfunction in hypertension-induced cardiac damage.

Authors:  Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Eur Heart J       Date:  2014-11-10       Impact factor: 29.983

Review 8.  Mitochondria in Sepsis-Induced AKI.

Authors:  Jian Sun; Jingxiao Zhang; Jiakun Tian; Grazia Maria Virzì; Kumar Digvijay; Laura Cueto; Yongjie Yin; Mitchell H Rosner; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2019-05-10       Impact factor: 10.121

Review 9.  Enhancing Mitochondrial Health to Treat Hypertension.

Authors:  Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Curr Hypertens Rep       Date:  2018-08-17       Impact factor: 5.369

Review 10.  Mitochondrial function and disturbances in the septic kidney.

Authors:  Samir M Parikh; Yuan Yang; Liyu He; Chengyuan Tang; Ming Zhan; Zheng Dong
Journal:  Semin Nephrol       Date:  2015-01       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.